Epidemiological evidence for a low abuse potential of zolpidem

Pharmacopsychiatry

Volumn 33, Issue 4, 2000, Pages 138-141

  Soyka, M ^a   Bottlender, R ^a   Moller, H J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; ZOLPIDEM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG ABUSE; DRUG DEPENDENCE; DRUG SAFETY; DRUG TOLERANCE; EPIDEMIOLOGICAL DATA; FEMALE; HIGH RISK PATIENT; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL;

ADULT; ANIMALS; FEMALE; GERMANY; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PYRIDINES; SUBSTANCE-RELATED DISORDERS;

EID: 0033902630     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-11224     Document Type: Article

References (59)

1. General safety profile of zolpidem: Safety in elderly, overdose and rebound effects
2. Psychotic reactions to zolpidem
3. Arzneimittelkommission der deutschen Arzteschaft. Keine Verordnung von Zolpidem bei bekannter Benzodiazepinabhangigkeit
4. Effects of zolpidem on sleep architecture and daytime psychomotor skills in poor sleepers
5. Zolpidem (10 mg and 20 mg): Hypnotic action and residual effects after a single bedtime dose
6. Zolpidem dependence in a patient with former polysubstance abuse
7. Misbrugspotentiale under brug og abstinenspsykose efter behandling med sovemidlet zolpidem (Stilnoct)
8. Tolerance and withdrawal with zolpidem
9. Zolpidem dependence
10. Neue Schlafmittel: Zopiclon und Zolpidem
11. Zolpidem, a novel non-benzodiazepine hypnotic. 1. Neuropharmacological and behavioral effects
12. Zolpidem, a novel nonbenzodiazepine hypnotic, I. Neuropharmacological and behavioral effects
13. Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions
14. Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability
15. Chronic abuse of zolpidem
16. Psychotrope und andere Arzneimittel mit Missbrauchs und Abhangigkeitspotential
17. Zolpidem behavioral pharmacology in baboons: Self-injection, discrimination, tolerance and withdrawal
18. Terapia dell'insomnia correlata con i disturbi depressivi. Studio in doppio cieco sugli effetti della somministrazione e della sospensione die zolpidem versus flunitrazepam in pazienti depressi insonni
19. Ungestilltes Verlangen: Abhangigkeits-syndrom von Zolpidem (Stilnox)
20. More on zolpidem side effects
21. Zolpidem-induced macropsia in anorexic woman
22. Zolpidem and Zopiclon. Geringeres Missbrauchspotential im Vergleich mit Benzodiazepin-Hypnotika
23. Missbrauchsmuster bei Abhangigkeit von Alkohol, Medikamenten und Drogen. Fruhwarnsystem-Daten fur die Bundesrepublik Deutschland 1976-1990
24. Effects de l'administration repetee de zolpidem 10 mg sur le sommeil et la vigilance diurne chez des mauvais dormeurs
25. Guidelines for the prevention and treatment of benzodiazepine dependence: Summary of a report from the Mental Health Foundation
26. Rebound insomnia and newer hypnotics
27. Zopiclone: Is there any dependence and abuse potential?
28. Limitations of the benzodiazepine receptor nomenclature: A proposal for a pharmacological classification as omega receptor subtypes
29. Gradual withdrawal of zopiclone (7,5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months
30. Controlled study of efficacy and safety of two oral doses of zolpidem (10 and 20 mg)
31. The safety and efficicacy of zolpidem in insomniac patients: A long-term open study in general practice
32. Double-blind controlled study of the efficacy and safety of zolpidem versus flunitrazepam
33. The dose effects of zolpidem on the sleep of healthy normals
34. Effect of zolpidem on sleep in insomniac patients
35. Zolpidem and rebound insomnia. A double-blind, controlled polysomnographic study in chronic insomniac patients
36. Zolpidem side effects
37. Wie 'neu' sind die Hypnotika Zopiclon und Zolpidem? Arzneiverordnung in der Praxis
38. Comparison of the efficacy and tolerability of zolpidem 20 mg and triazolam 0.5 mg in anxious or depressed insomniac patients
39. Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics
40. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem
41. Zolpidem tolerance and dependence - Two case reports
42. Effects of zolpidem on saccadic eye movements and psychomotor performance: A double-blind, placebo cotrolled study in healthy volunteers
43. Rebound insomnia potential of zolpidem 10mg as evaluated by three different methods
44. Dependence on zolpidem: A case report
45. Dependence and tolerance with zolpidem
46. Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega modulatory sites of GABA A receptors
47. Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296
48. The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic
49. Dependence on zolpidem: Case report
50. Open long-term trials with zolpidem in insomnia
51. Open long-term trials with zolpidem in insomnia
52. Efficacite comparative de la doxylamine (15 mg) et du zolpidem (10 mg) dans le traitement de l'insomnie commune
53. Dose-response of zolpidem in elderly patients with chronic insomnia
54. Long-term treatment of insomnia with zolpidem: A multicentre general practitioner study of 107 patients
55. Dependency of non-benzodiazepine hypnotics. Two case reports
56. Zolpidem-Abhangigkeit und Depression im Senium
57. Studies of effects following discontinuation of zolpidem treatment
58. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons
59. Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective